MENU
SYRE
AS OF
Jan 30 closing price
Price
$31.98
Change
-$1.60 (-4.76%)
Capitalization
2.48B
24 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
SYRE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Spyre Therapeutics (SYRE) Ownership - Who owns Spyre Therapeutics?

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
221 Crescent Street
Phone
+1 617 651-5940
Employees
30
Web
https://www.spyre.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.48B
P/E Ratio
1.72
Total Cash
486.2M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
5.38
Dividend Yield
N/A
Total Cash/Share
6.27
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

SYRE
Capitalization
2.48B
P/E Ratio
1.72
Risk (Beta)
5.38
Dividend Yield
N/A
Total Cash
486M
Total Cash/Share
6.27
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
299M
P/B Ratio
8.29
Cash Flow
N/A
Earnings
-1.32
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
13K
Current Ratio
10.90
Current Revenue Per Employee
49142.86
Dividends Per Share - Security
N/A
EBITDA
-223.64M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-19.55
Shares Held By Institutions
1.96B
Shares Outstanding - Current
77.6M
Total Liabilities
49.5M
Total Volume MTD
N/A
Value
-1
Gain YTD
-2.381
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
SYRE
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SYRE showed earnings on November 04, 2025. You can read more about the earnings report here.
View AI-Driven Trading for SYRE
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
221 Crescent Street
Phone
+1 617 651-5940
Employees
30
Web
https://www.spyre.com